• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Infectious Disease

Postmarket surveillance programs largest source of safety data triggering vaccine label changes

bySze Wah Samuel ChanandDeepti Shroff, DMD, MS
July 28, 2020
in Infectious Disease, Public Health
Reading Time: 2 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. Postmarketing surveillance programs of Food and Drug Administration approved vaccines were the most common source of safety data triggering safety label changes.

2. The most common safety label changes included changes in population restrictions and allergies.

Evidence Rating Level: 3 (Average)

Study Rundown: Food and Drug Administration (FDA) approved vaccines undergo postmarket surveillance to identify uncommon and long-term adverse events. For example, the Vaccine Adverse Event Reporting System (VAERS) is a national vaccine safety surveillance program established to monitor approved vaccines. The authors analyzed the initial and approved labels of a cohort of approved infectious disease vaccines to assess postmarket label changes. The most frequent reason for a safety modification was for changes to population restriction, allergies and postvaccination syncope. One vaccine (RotaShield) was withdrawn for safety issues identified through VAERS. The most common source of safety data was postmarketing surveillance. The study highlighted that the majority of vaccine safety label changes were not clinically significant. Moreover, it emphasized the importance of independent monitoring systems in assessing long term complications. However, the study was limited by the availability of public data as not all safety data received by the FDA was included in the study.

Click to read the study, published today in Annals of Internal Medicine

Relevant Reading: Vaccination errors reported to the Vaccine Adverse Event Reporting System, (VAERS) United States, 2000-2013

RELATED REPORTS

CDC reports increasing early-season influenza activity and at least 900 deaths nationwide

Pennsylvania reports 1,260 measles cases across 43 counties in 2026

In-Depth [retrospective cohort]: In this retrospective cohort study, 57 FDA-approved vaccines were analyzed from 1996 – 2015. The most common approved vaccine was the season influenza vaccine (37%). 58 postapproval label modifications were analyzed. The most common safety issue triggering a label change was increased population restrictions (36%) to include immunocompromised patients, specific preexisting conditions, premature infants and pregnant women. The next most common label change was related to allergies (22%), mostly due to latex packaging. 21% were related to postvaccination syncope. The most common source of safety data was postmarketing surveillance (48%), followed by manufacturer warnings from changes in packaging materials (21%).

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Food and Drug Administration (FDA)immunizationvaccination
Previous Post

A sibling-adoption design for the study of genetic and environmental influence on children’s body mass index #VA

Next Post

Sodium glucose cotransporter-2 inhibitor use associated with increased risk of diabetic ketoacidosis

RelatedReports

The image features vials of a vaccine, a patient using a respiratory device, and medical devices highlighting aspects of infectious disease management, likely related to influenza.
2MM Trial Briefs

CDC reports increasing early-season influenza activity and at least 900 deaths nationwide

October 31, 2026
An illustration depicting two syringes near a stylized representation of a human arm, symbolizing the administration of flu and COVID-19 vaccinations.
2MM Trial Briefs

Pennsylvania reports 1,260 measles cases across 43 counties in 2026

October 27, 2026
An illustration showing a vaccine vial, a protective shield, and an mRNA strand alongside influenza virus particles, symbolizing the mRNA flu vaccine.
Pharma

First messenger RNA influenza vaccine outperforms standard-dose vaccination

September 15, 2026
Pain control after surgery collage: an older woman resting on a hospital pillow beside a teal nerve that branches at one end
Infectious Disease

Concomitant COVID-19 and influenza vaccination not linked to increased adverse events

June 29, 2026
Next Post

Sodium glucose cotransporter-2 inhibitor use associated with increased risk of diabetic ketoacidosis

#VisualAbstract: Vitamin D Supplements for Prevention of Tuberculosis Infection and Disease

#VisualAbstract: Vitamin D Supplements for Prevention of Tuberculosis Infection and Disease

Feasibility of a school-based vision screening program for kindergarten children in Ontario #VA

Feasibility of a school-based vision screening program for kindergarten children in Ontario #VA

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Less social media usage is associated with improved internalizing symptoms in high-risk young adults.
  • AI cardiac MRI analysis marginally outperforms clinicians in predicting all-cause mortality
  • In a phase 3 trial, tirzepatide reduced BMI versus placebo in adolescents with obesity and obesity-related complications
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.